ArticleScientific reports2025
Patients knowledge attitudes and practices regarding superficial fungal infections suggest public health and patient education are warranted.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Pharmacological assessment of drugs retained in the 1Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Lipid-based nanocarriers for antifungal drug delivery.Discover nano · 2026Review
- Analysis of pathogen spectrum changes and epidemiological characteristics of superficial mycosis in the Shantou region of China from 2022 to 2024.American journal of translational research · 2026Article
- Exploring the Diversity and Distribution of Medico-Veterinary Fungal Diseases in Africa: Harnessing a Multisectoral One Health Strategy for Cost-Effective Prevention and Preparedness.Journal of fungi (Basel, Switzerland) · 2025Review
- Multilevel obstacles to heart-healthy living in the context of Ischemic heart disease: A qualitative study.PloS one · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Superficial fungal infections are common worldwide and significantly impact public health. Understanding patients' knowledge, attitudes, and practices (KAP) regarding their treatment and prognosis is essential for addressing gaps in care. This cross-sectional study utilized a self-designed KAP questionnaire to assess 456 patients with superficial fungal infections between October 15, 2023, and March 15, 2024. Data analysis included descriptive statistics, logistic regression, and structural equation modeling. The mean scores for knowledge, attitudes, and practices were 14.85 ± 7.75, 27.01 ± 4.28, and 22.91 ± 4.17, respectively. Key findings revealed that 32% of patients were unsure about long-term treatment, 51% misunderstood corticosteroid use, and 69% believed medications could be stopped once symptoms improved. Significant demographic disparities in KAP scores were observed, highlighting the influence of gender, age, education, and income. Patients exhibit inadequate knowledge, predominantly negative attitudes, and suboptimal practices regarding superficial fungal infections. Targeted educational interventions are crucial for enhancing treatment adherence, addressing misconceptions, and reducing antifungal resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.